Event Details

Indegene Limited hosted the eighth edition of the Indegene Digital Summit on September 22, 2026, at the National Constitution Center in Philadelphia. The invitation-only event brought together 200+ leaders from across the global life sciences ecosystem for peer-led discussions without sales pitches or vendor noise.

Summit Theme and Focus

The theme was "From Promise to Performance: Operationalizing AI for Enterprise Outcomes," focusing on translating AI investment into business outcomes. Discussions examined why applying AI to traditional operating models is insufficient and what companies must change in work, data, decisions, content, governance, talent, and partnerships.

Key Discussion Topics

  • Customer engagement in 2028
  • Future of work
  • AI-enabled launch models
  • AI-native revenue maximization
  • Connection between AI and profit-and-loss impact
  • Changes in U.S. drug approval and pricing policy
  • Point-of-care AI
  • Role of chief digital and information officer in shaping pharma's AI agenda
  • Digital capabilities and global operating models to improve customer experience

Featured Speakers

  • David Shulkin, Ninth Secretary of the U.S. Department of Veterans Affairs
  • Amol Punjabi, Chief Product Officer, Open Evidence
  • Agam Upadhyay, SVP and Chief Digital & Information Officer, Vertex Pharmaceuticals
  • Corinne Le Goff, Chief Commercial Officer, Viatris
  • Chumi Khurana, SVP, U.S. Oncology Franchise Head, Jazz Pharmaceuticals
  • Jeremy Shepler, VP, Commercial DAS Leader, J&J Innovative Medicine
  • Radife Kiral, CFC Capabilities and Commercial Excellence Lead, Pfizer
  • Kate Duffy, Marketing AI Product Lead, AIA, Pfizer
  • Madelene Glomsten, Head of Global Marketing, Sanofi
  • Saket Malhotra, Global Head of Commercial Digital, BioMarin Pharmaceutical Inc.
  • Shane Schaffer, CEO and Chairman, Cingulate Therapeutics
  • Shaan Gandhi, VP and Head of Partnerships PAVE, Pfizer
  • Steve Winawer, Sun Pharma
  • Tarun Mathur, Chief Technology Officer, Indegene

Key Summit Themes

Broad-based recognition that operationalizing AI for business impact requires a next-generation, life-sciences native operating model powered by domain understanding, experience and context. Beyond operational efficiency, AI can help connect data, intelligence and evidence to enable strategic decisions, drive successful product launches, deliver more personalized customer experiences and accelerate drug discovery and clinical research.

CEO Commentary

Manish Gupta, Chairman and CEO of Indegene, stated: "Life sciences has built an extraordinary legacy of helping people live longer, healthier lives. But increasingly specialized therapies and precision medicines cannot be supported by operating models designed for an era of mass promotion. The opportunity now is to thoughtfully rewire the enterprise around AI, augment our people, and build systems that are smarter, faster, and more responsive, turning the promise of technology into measurable performance for patients, physicians, and the business."

VITAL Awards 2026

The summit hosted the second edition of the VITAL Awards, recognizing life sciences leaders delivering measurable industry impact. Awards were presented in two jury-evaluated categories:

Organizational Impact: Leaders driving meaningful change within their organizations through new operating models, capabilities, collaboration, technology adoption, or ways of working.

Market Impact: Leaders delivering measurable market impact through launch strategy, commercialization models, customer engagement, portfolio growth, or operational execution.

Award Jury Members

  • Jill DeSimone, former U.S. Head of Oncology, Merck
  • David Shulkin, Ninth Secretary, U.S. Department of Veterans Affairs
  • Michelle Keefe, former CEO, Syneos Health
  • Aida Habtezion, former Chief Medical Officer, Pfizer
  • Rohan Kulkarni, Executive Research Leader, HFS Research
  • Jameson Fleming, former Chief Editor, MM+M
  • Dr. Rajesh Nair, President, Indegene, Inc.

VITAL Awards 2026 Honorees

Transformational Leadership: Brian Cantwell, VP, Head of AI, US Pharma, Bayer; and Agam Upadhyay, SVP, Chief Digital and Information Officer, Vertex.

Organizational Impact: Amanda Marvel, Senior Marketing Director, Gilead Sciences; and Saket Malhotra, Global Head of Commercial Digital, BioMarin.

Market Impact: Lauren Jones, Head of Digital Marketing, Incyte; and Nicholas Lucente, US Product Lead, Secondary Stroke Prevention, Bayer.

Additional Information

Indegene Digital Summit is Indegene's flagship thought leadership platform for the life sciences industry, facilitating dialogue among senior executives, regulators, and digital innovators. A #FutureReadyHealthcare initiative, the Summit is orchestrated by Indegene.

Session recordings, summaries, and more information available at: https://digitalsummit.indegene.com/

Company Background

Indegene Limited (BSE: 544172, NSE: INDGN) is the strategic operating partner to the life sciences industry, orchestrating commercial, medical, R&D, and safety operations across the product lifecycle. The company is trusted by the world's top 20 biopharma companies and helps run complex, highly regulated workflows at global scale.